The global market for Sorafenib Tosylate API was estimated to be worth US$ 35 million in 2023 and is forecast to a readjusted size of US$ 53 million by 2030 with a CAGR of 5.8% during the forecast period 2024-2030

Sorafenib Tosylate API - Market

Sorafenib Tosylate is an active pharmaceutical ingredient (API) that is used in the treatment of certain types of cancer, including advanced renal cell carcinoma and hepatocellular carcinoma. It works by blocking the action of enzymes and proteins that are involved in cancer cell growth and division.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Sorafenib Tosylate API, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Sorafenib Tosylate API by region & country, by Type, and by Application.

The Sorafenib Tosylate API market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sorafenib Tosylate API.

Market Segmentation

Scope of Sorafenib Tosylate API - Market Report

Report Metric	Details
Report Name	Sorafenib Tosylate API - Market
Forecasted market size in 2030	US$ 53 million
CAGR	5.8%
Forecasted years	2024 - 2030
Segment by Type:	FormⅠ Form Ⅲ
Segment by Application	Pharmaceutical Scientific Research Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Teva API, Natco Pharma, Cipla, Alembic Pharmaceutical, Hetero, Aurobindo Pharma, Sun Pharmaceutical Industries, BDR Lifesciences, Delmar Chemicals, Yabao Pharmaceutical Group, Sichuan Xieli Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Sorafenib Tosylate API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Sorafenib Tosylate API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Sorafenib Tosylate API in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Sorafenib Tosylate API - Market size in 2030?

Ans: The Sorafenib Tosylate API - Market size in 2030 will be US$ 53 million.

Who are the main players in the Sorafenib Tosylate API - Market report?

Ans: The main players in the Sorafenib Tosylate API - Market are Teva API, Natco Pharma, Cipla, Alembic Pharmaceutical, Hetero, Aurobindo Pharma, Sun Pharmaceutical Industries, BDR Lifesciences, Delmar Chemicals, Yabao Pharmaceutical Group, Sichuan Xieli Pharmaceutical

What are the Application segmentation covered in the Sorafenib Tosylate API - Market report?

Ans: The Applications covered in the Sorafenib Tosylate API - Market report are Pharmaceutical, Scientific Research, Other

What are the Type segmentation covered in the Sorafenib Tosylate API - Market report?

Ans: The Types covered in the Sorafenib Tosylate API - Market report are FormⅠ, Form Ⅲ

1 Market Overview

1.1 Sorafenib Tosylate API Product Introduction

1.2 Global Sorafenib Tosylate API Market Size Forecast

1.2.1 Global Sorafenib Tosylate API Sales Value (2019-2030)

1.2.2 Global Sorafenib Tosylate API Sales Volume (2019-2030)

1.2.3 Global Sorafenib Tosylate API Sales Price (2019-2030)

1.3 Sorafenib Tosylate API Market Trends & Drivers

1.3.1 Sorafenib Tosylate API Industry Trends

1.3.2 Sorafenib Tosylate API Market Drivers & Opportunity

1.3.3 Sorafenib Tosylate API Market Challenges

1.3.4 Sorafenib Tosylate API Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Sorafenib Tosylate API Players Revenue Ranking (2023)

2.2 Global Sorafenib Tosylate API Revenue by Company (2019-2024)

2.3 Global Sorafenib Tosylate API Players Sales Volume Ranking (2023)

2.4 Global Sorafenib Tosylate API Sales Volume by Company Players (2019-2024)

2.5 Global Sorafenib Tosylate API Average Price by Company (2019-2024)

2.6 Key Manufacturers Sorafenib Tosylate API Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Sorafenib Tosylate API Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Sorafenib Tosylate API

2.9 Sorafenib Tosylate API Market Competitive Analysis

2.9.1 Sorafenib Tosylate API Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Sorafenib Tosylate API Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sorafenib Tosylate API as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 FormⅠ

3.1.2 Form Ⅲ

3.2 Global Sorafenib Tosylate API Sales Value by Type

3.2.1 Global Sorafenib Tosylate API Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Sorafenib Tosylate API Sales Value, by Type (2019-2030)

3.2.3 Global Sorafenib Tosylate API Sales Value, by Type (%) (2019-2030)

3.3 Global Sorafenib Tosylate API Sales Volume by Type

3.3.1 Global Sorafenib Tosylate API Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Sorafenib Tosylate API Sales Volume, by Type (2019-2030)

3.3.3 Global Sorafenib Tosylate API Sales Volume, by Type (%) (2019-2030)

3.4 Global Sorafenib Tosylate API Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Pharmaceutical

4.1.2 Scientific Research

4.1.3 Other

4.2 Global Sorafenib Tosylate API Sales Value by Application

4.2.1 Global Sorafenib Tosylate API Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Sorafenib Tosylate API Sales Value, by Application (2019-2030)

4.2.3 Global Sorafenib Tosylate API Sales Value, by Application (%) (2019-2030)

4.3 Global Sorafenib Tosylate API Sales Volume by Application

4.3.1 Global Sorafenib Tosylate API Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Sorafenib Tosylate API Sales Volume, by Application (2019-2030)

4.3.3 Global Sorafenib Tosylate API Sales Volume, by Application (%) (2019-2030)

4.4 Global Sorafenib Tosylate API Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Sorafenib Tosylate API Sales Value by Region

5.1.1 Global Sorafenib Tosylate API Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Sorafenib Tosylate API Sales Value by Region (2019-2024)

5.1.3 Global Sorafenib Tosylate API Sales Value by Region (2025-2030)

5.1.4 Global Sorafenib Tosylate API Sales Value by Region (%), (2019-2030)

5.2 Global Sorafenib Tosylate API Sales Volume by Region

5.2.1 Global Sorafenib Tosylate API Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Sorafenib Tosylate API Sales Volume by Region (2019-2024)

5.2.3 Global Sorafenib Tosylate API Sales Volume by Region (2025-2030)

5.2.4 Global Sorafenib Tosylate API Sales Volume by Region (%), (2019-2030)

5.3 Global Sorafenib Tosylate API Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Sorafenib Tosylate API Sales Value, 2019-2030

5.4.2 North America Sorafenib Tosylate API Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Sorafenib Tosylate API Sales Value, 2019-2030

5.5.2 Europe Sorafenib Tosylate API Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Sorafenib Tosylate API Sales Value, 2019-2030

5.6.2 Asia Pacific Sorafenib Tosylate API Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Sorafenib Tosylate API Sales Value, 2019-2030

5.7.2 South America Sorafenib Tosylate API Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Sorafenib Tosylate API Sales Value, 2019-2030

5.8.2 Middle East & Africa Sorafenib Tosylate API Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Sorafenib Tosylate API Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Sorafenib Tosylate API Sales Value

6.2.1 Key Countries/Regions Sorafenib Tosylate API Sales Value, 2019-2030

6.2.2 Key Countries/Regions Sorafenib Tosylate API Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Sorafenib Tosylate API Sales Value, 2019-2030

6.3.2 United States Sorafenib Tosylate API Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Sorafenib Tosylate API Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Sorafenib Tosylate API Sales Value, 2019-2030

6.4.2 Europe Sorafenib Tosylate API Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Sorafenib Tosylate API Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Sorafenib Tosylate API Sales Value, 2019-2030

6.5.2 China Sorafenib Tosylate API Sales Value by Type (%), 2023 VS 2030

6.5.3 China Sorafenib Tosylate API Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Sorafenib Tosylate API Sales Value, 2019-2030

6.6.2 Japan Sorafenib Tosylate API Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Sorafenib Tosylate API Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Sorafenib Tosylate API Sales Value, 2019-2030

6.7.2 South Korea Sorafenib Tosylate API Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Sorafenib Tosylate API Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Sorafenib Tosylate API Sales Value, 2019-2030

6.8.2 Southeast Asia Sorafenib Tosylate API Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Sorafenib Tosylate API Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Sorafenib Tosylate API Sales Value, 2019-2030

6.9.2 India Sorafenib Tosylate API Sales Value by Type (%), 2023 VS 2030

6.9.3 India Sorafenib Tosylate API Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Teva API

7.1.1 Teva API Company Information

7.1.2 Teva API Introduction and Business Overview

7.1.3 Teva API Sorafenib Tosylate API Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Teva API Sorafenib Tosylate API Product Offerings

7.1.5 Teva API Recent Development

7.2 Natco Pharma

7.2.1 Natco Pharma Company Information

7.2.2 Natco Pharma Introduction and Business Overview

7.2.3 Natco Pharma Sorafenib Tosylate API Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Natco Pharma Sorafenib Tosylate API Product Offerings

7.2.5 Natco Pharma Recent Development

7.3 Cipla

7.3.1 Cipla Company Information

7.3.2 Cipla Introduction and Business Overview

7.3.3 Cipla Sorafenib Tosylate API Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Cipla Sorafenib Tosylate API Product Offerings

7.3.5 Cipla Recent Development

7.4 Alembic Pharmaceutical

7.4.1 Alembic Pharmaceutical Company Information

7.4.2 Alembic Pharmaceutical Introduction and Business Overview

7.4.3 Alembic Pharmaceutical Sorafenib Tosylate API Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Alembic Pharmaceutical Sorafenib Tosylate API Product Offerings

7.4.5 Alembic Pharmaceutical Recent Development

7.5 Hetero

7.5.1 Hetero Company Information

7.5.2 Hetero Introduction and Business Overview

7.5.3 Hetero Sorafenib Tosylate API Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Hetero Sorafenib Tosylate API Product Offerings

7.5.5 Hetero Recent Development

7.6 Aurobindo Pharma

7.6.1 Aurobindo Pharma Company Information

7.6.2 Aurobindo Pharma Introduction and Business Overview

7.6.3 Aurobindo Pharma Sorafenib Tosylate API Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Aurobindo Pharma Sorafenib Tosylate API Product Offerings

7.6.5 Aurobindo Pharma Recent Development

7.7 Sun Pharmaceutical Industries

7.7.1 Sun Pharmaceutical Industries Company Information

7.7.2 Sun Pharmaceutical Industries Introduction and Business Overview

7.7.3 Sun Pharmaceutical Industries Sorafenib Tosylate API Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Sun Pharmaceutical Industries Sorafenib Tosylate API Product Offerings

7.7.5 Sun Pharmaceutical Industries Recent Development

7.8 BDR Lifesciences

7.8.1 BDR Lifesciences Company Information

7.8.2 BDR Lifesciences Introduction and Business Overview

7.8.3 BDR Lifesciences Sorafenib Tosylate API Sales, Revenue and Gross Margin (2019-2024)

7.8.4 BDR Lifesciences Sorafenib Tosylate API Product Offerings

7.8.5 BDR Lifesciences Recent Development

7.9 Delmar Chemicals

7.9.1 Delmar Chemicals Company Information

7.9.2 Delmar Chemicals Introduction and Business Overview

7.9.3 Delmar Chemicals Sorafenib Tosylate API Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Delmar Chemicals Sorafenib Tosylate API Product Offerings

7.9.5 Delmar Chemicals Recent Development

7.10 Yabao Pharmaceutical Group

7.10.1 Yabao Pharmaceutical Group Company Information

7.10.2 Yabao Pharmaceutical Group Introduction and Business Overview

7.10.3 Yabao Pharmaceutical Group Sorafenib Tosylate API Sales, Revenue and Gross Margin (2019-2024)

7.10.4 Yabao Pharmaceutical Group Sorafenib Tosylate API Product Offerings

7.10.5 Yabao Pharmaceutical Group Recent Development

7.11 Sichuan Xieli Pharmaceutical

7.11.1 Sichuan Xieli Pharmaceutical Company Information

7.11.2 Sichuan Xieli Pharmaceutical Introduction and Business Overview

7.11.3 Sichuan Xieli Pharmaceutical Sorafenib Tosylate API Sales, Revenue and Gross Margin (2019-2024)

7.11.4 Sichuan Xieli Pharmaceutical Sorafenib Tosylate API Product Offerings

7.11.5 Sichuan Xieli Pharmaceutical Recent Development

8 Industry Chain Analysis

8.1 Sorafenib Tosylate API Industrial Chain

8.2 Sorafenib Tosylate API Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Sorafenib Tosylate API Sales Model

8.5.2 Sales Channel

8.5.3 Sorafenib Tosylate API Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Teva API

Natco Pharma

Cipla Ltd

Alembic Pharmaceutical

Hetero

Aurobindo Pharma

Sun Pharmaceutical Industries

Delmar Chemicals

Yabao Pharmaceutical Group

Sichuan Xieli Pharmaceutical

BDR Lifesciences

List of Tables

Table 1. Sorafenib Tosylate API Market Trends

Table 2. Sorafenib Tosylate API Market Drivers & Opportunity

Table 3. Sorafenib Tosylate API Market Challenges

Table 4. Sorafenib Tosylate API Market Restraints

Table 5. Global Sorafenib Tosylate API Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Sorafenib Tosylate API Revenue Market Share by Company (2019-2024)

Table 7. Global Sorafenib Tosylate API Sales Volume by Company (2019-2024) & (Tons)

Table 8. Global Sorafenib Tosylate API Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Sorafenib Tosylate API Price by Company (2019-2024) & (US$/Ton)

Table 10. Key Manufacturers Sorafenib Tosylate API Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Sorafenib Tosylate API Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Sorafenib Tosylate API

Table 13. Global Sorafenib Tosylate API Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sorafenib Tosylate API as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Sorafenib Tosylate API Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Sorafenib Tosylate API Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Sorafenib Tosylate API Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Sorafenib Tosylate API Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Sorafenib Tosylate API Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Sorafenib Tosylate API Sales Volume by Type: 2019 VS 2023 VS 2030 (Tons)

Table 22. Global Sorafenib Tosylate API Sales Volume by Type (2019-2024) & (Tons)

Table 23. Global Sorafenib Tosylate API Sales Volume by Type (2025-2030) & (Tons)

Table 24. Global Sorafenib Tosylate API Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Sorafenib Tosylate API Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Sorafenib Tosylate API Price by Type (2019-2024) & (US$/Ton)

Table 27. Global Sorafenib Tosylate API Price by Type (2025-2030) & (US$/Ton)

Table 28. Global Sorafenib Tosylate API Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Sorafenib Tosylate API Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Sorafenib Tosylate API Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Sorafenib Tosylate API Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Sorafenib Tosylate API Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Sorafenib Tosylate API Sales Volume by Application: 2019 VS 2023 VS 2030 (Tons)

Table 34. Global Sorafenib Tosylate API Sales Volume by Application (2019-2024) & (Tons)

Table 35. Global Sorafenib Tosylate API Sales Volume by Application (2025-2030) & (Tons)

Table 36. Global Sorafenib Tosylate API Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Sorafenib Tosylate API Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Sorafenib Tosylate API Price by Application (2019-2024) & (US$/Ton)

Table 39. Global Sorafenib Tosylate API Price by Application (2025-2030) & (US$/Ton)

Table 40. Global Sorafenib Tosylate API Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Sorafenib Tosylate API Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Sorafenib Tosylate API Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Sorafenib Tosylate API Sales Value by Region (2019-2024) & (%)

Table 44. Global Sorafenib Tosylate API Sales Value by Region (2025-2030) & (%)

Table 45. Global Sorafenib Tosylate API Sales Volume by Region (Tons): 2019 VS 2023 VS 2030

Table 46. Global Sorafenib Tosylate API Sales Volume by Region (2019-2024) & (Tons)

Table 47. Global Sorafenib Tosylate API Sales Volume by Region (2025-2030) & (Tons)

Table 48. Global Sorafenib Tosylate API Sales Volume by Region (2019-2024) & (%)

Table 49. Global Sorafenib Tosylate API Sales Volume by Region (2025-2030) & (%)

Table 50. Global Sorafenib Tosylate API Average Price by Region (2019-2024) & (US$/Ton)

Table 51. Global Sorafenib Tosylate API Average Price by Region (2025-2030) & (US$/Ton)

Table 52. Key Countries/Regions Sorafenib Tosylate API Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Sorafenib Tosylate API Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Sorafenib Tosylate API Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Sorafenib Tosylate API Sales Volume, (2019-2024) & (Tons)

Table 56. Key Countries/Regions Sorafenib Tosylate API Sales Volume, (2025-2030) & (Tons)

Table 57. Teva API Company Information

Table 58. Teva API Introduction and Business Overview

Table 59. Teva API Sorafenib Tosylate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 60. Teva API Sorafenib Tosylate API Product Offerings

Table 61. Teva API Recent Development

Table 62. Natco Pharma Company Information

Table 63. Natco Pharma Introduction and Business Overview

Table 64. Natco Pharma Sorafenib Tosylate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 65. Natco Pharma Sorafenib Tosylate API Product Offerings

Table 66. Natco Pharma Recent Development

Table 67. Cipla Company Information

Table 68. Cipla Introduction and Business Overview

Table 69. Cipla Sorafenib Tosylate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 70. Cipla Sorafenib Tosylate API Product Offerings

Table 71. Cipla Recent Development

Table 72. Alembic Pharmaceutical Company Information

Table 73. Alembic Pharmaceutical Introduction and Business Overview

Table 74. Alembic Pharmaceutical Sorafenib Tosylate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 75. Alembic Pharmaceutical Sorafenib Tosylate API Product Offerings

Table 76. Alembic Pharmaceutical Recent Development

Table 77. Hetero Company Information

Table 78. Hetero Introduction and Business Overview

Table 79. Hetero Sorafenib Tosylate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 80. Hetero Sorafenib Tosylate API Product Offerings

Table 81. Hetero Recent Development

Table 82. Aurobindo Pharma Company Information

Table 83. Aurobindo Pharma Introduction and Business Overview

Table 84. Aurobindo Pharma Sorafenib Tosylate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 85. Aurobindo Pharma Sorafenib Tosylate API Product Offerings

Table 86. Aurobindo Pharma Recent Development

Table 87. Sun Pharmaceutical Industries Company Information

Table 88. Sun Pharmaceutical Industries Introduction and Business Overview

Table 89. Sun Pharmaceutical Industries Sorafenib Tosylate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 90. Sun Pharmaceutical Industries Sorafenib Tosylate API Product Offerings

Table 91. Sun Pharmaceutical Industries Recent Development

Table 92. BDR Lifesciences Company Information

Table 93. BDR Lifesciences Introduction and Business Overview

Table 94. BDR Lifesciences Sorafenib Tosylate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 95. BDR Lifesciences Sorafenib Tosylate API Product Offerings

Table 96. BDR Lifesciences Recent Development

Table 97. Delmar Chemicals Company Information

Table 98. Delmar Chemicals Introduction and Business Overview

Table 99. Delmar Chemicals Sorafenib Tosylate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 100. Delmar Chemicals Sorafenib Tosylate API Product Offerings

Table 101. Delmar Chemicals Recent Development

Table 102. Yabao Pharmaceutical Group Company Information

Table 103. Yabao Pharmaceutical Group Introduction and Business Overview

Table 104. Yabao Pharmaceutical Group Sorafenib Tosylate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 105. Yabao Pharmaceutical Group Sorafenib Tosylate API Product Offerings

Table 106. Yabao Pharmaceutical Group Recent Development

Table 107. Sichuan Xieli Pharmaceutical Company Information

Table 108. Sichuan Xieli Pharmaceutical Introduction and Business Overview

Table 109. Sichuan Xieli Pharmaceutical Sorafenib Tosylate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 110. Sichuan Xieli Pharmaceutical Sorafenib Tosylate API Product Offerings

Table 111. Sichuan Xieli Pharmaceutical Recent Development

Table 112. Key Raw Materials Lists

Table 113. Raw Materials Key Suppliers Lists

Table 114. Sorafenib Tosylate API Downstream Customers

Table 115. Sorafenib Tosylate API Distributors List

Table 116. Research Programs/Design for This Report

Table 117. Key Data Information from Secondary Sources

Table 118. Key Data Information from Primary Sources

List of Figures

Figure 1. Sorafenib Tosylate API Product Picture

Figure 2. Global Sorafenib Tosylate API Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Sorafenib Tosylate API Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Sorafenib Tosylate API Sales Volume (2019-2030) & (Tons)

Figure 5. Global Sorafenib Tosylate API Sales Price (2019-2030) & (US$/Ton)

Figure 6. Sorafenib Tosylate API Report Years Considered

Figure 7. Global Sorafenib Tosylate API Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Sorafenib Tosylate API Players Sales Volume Ranking (2023) & (Tons)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Sorafenib Tosylate API Revenue in 2023

Figure 10. Sorafenib Tosylate API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. FormⅠ Picture

Figure 12. Form Ⅲ Picture

Figure 13. Global Sorafenib Tosylate API Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Sorafenib Tosylate API Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Sorafenib Tosylate API Sales Volume by Type (2019 VS 2023 VS 2030) & (Tons)

Figure 16. Global Sorafenib Tosylate API Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Sorafenib Tosylate API Price by Type (2019-2030) & (US$/Ton)

Figure 18. Product Picture of Pharmaceutical

Figure 19. Product Picture of Scientific Research

Figure 20. Product Picture of Other

Figure 21. Global Sorafenib Tosylate API Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 22. Global Sorafenib Tosylate API Sales Value Market Share by Application, 2023 & 2030

Figure 23. Global Sorafenib Tosylate API Sales Volume by Application (2019 VS 2023 VS 2030) & (Tons)

Figure 24. Global Sorafenib Tosylate API Sales Volume Market Share by Application, 2023 & 2030

Figure 25. Global Sorafenib Tosylate API Price by Application (2019-2030) & (US$/Ton)

Figure 26. North America Sorafenib Tosylate API Sales Value (2019-2030) & (US$ Million)

Figure 27. North America Sorafenib Tosylate API Sales Value by Country (%), 2023 VS 2030

Figure 28. Europe Sorafenib Tosylate API Sales Value (2019-2030) & (US$ Million)

Figure 29. Europe Sorafenib Tosylate API Sales Value by Country (%), 2023 VS 2030

Figure 30. Asia Pacific Sorafenib Tosylate API Sales Value (2019-2030) & (US$ Million)

Figure 31. Asia Pacific Sorafenib Tosylate API Sales Value by Country (%), 2023 VS 2030

Figure 32. South America Sorafenib Tosylate API Sales Value (2019-2030) & (US$ Million)

Figure 33. South America Sorafenib Tosylate API Sales Value by Country (%), 2023 VS 2030

Figure 34. Middle East & Africa Sorafenib Tosylate API Sales Value (2019-2030) & (US$ Million)

Figure 35. Middle East & Africa Sorafenib Tosylate API Sales Value by Country (%), 2023 VS 2030

Figure 36. Key Countries/Regions Sorafenib Tosylate API Sales Value (%), (2019-2030)

Figure 37. Key Countries/Regions Sorafenib Tosylate API Sales Volume (%), (2019-2030)

Figure 38. United States Sorafenib Tosylate API Sales Value, (2019-2030) & (US$ Million)

Figure 39. United States Sorafenib Tosylate API Sales Value by Type (%), 2023 VS 2030

Figure 40. United States Sorafenib Tosylate API Sales Value by Application (%), 2023 VS 2030

Figure 41. Europe Sorafenib Tosylate API Sales Value, (2019-2030) & (US$ Million)

Figure 42. Europe Sorafenib Tosylate API Sales Value by Type (%), 2023 VS 2030

Figure 43. Europe Sorafenib Tosylate API Sales Value by Application (%), 2023 VS 2030

Figure 44. China Sorafenib Tosylate API Sales Value, (2019-2030) & (US$ Million)

Figure 45. China Sorafenib Tosylate API Sales Value by Type (%), 2023 VS 2030

Figure 46. China Sorafenib Tosylate API Sales Value by Application (%), 2023 VS 2030

Figure 47. Japan Sorafenib Tosylate API Sales Value, (2019-2030) & (US$ Million)

Figure 48. Japan Sorafenib Tosylate API Sales Value by Type (%), 2023 VS 2030

Figure 49. Japan Sorafenib Tosylate API Sales Value by Application (%), 2023 VS 2030

Figure 50. South Korea Sorafenib Tosylate API Sales Value, (2019-2030) & (US$ Million)

Figure 51. South Korea Sorafenib Tosylate API Sales Value by Type (%), 2023 VS 2030

Figure 52. South Korea Sorafenib Tosylate API Sales Value by Application (%), 2023 VS 2030

Figure 53. Southeast Asia Sorafenib Tosylate API Sales Value, (2019-2030) & (US$ Million)

Figure 54. Southeast Asia Sorafenib Tosylate API Sales Value by Type (%), 2023 VS 2030

Figure 55. Southeast Asia Sorafenib Tosylate API Sales Value by Application (%), 2023 VS 2030

Figure 56. India Sorafenib Tosylate API Sales Value, (2019-2030) & (US$ Million)

Figure 57. India Sorafenib Tosylate API Sales Value by Type (%), 2023 VS 2030

Figure 58. India Sorafenib Tosylate API Sales Value by Application (%), 2023 VS 2030

Figure 59. Sorafenib Tosylate API Industrial Chain

Figure 60. Sorafenib Tosylate API Manufacturing Cost Structure

Figure 61. Channels of Distribution (Direct Sales, and Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions